Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
Chronic, inflammatory pain is an international health concern that severely diminishes individuals’ quality of life. Catalpol is an iridoid glycoside derived from the roots of Rehmannia glutinosa that possesses anti-inflammatory, antioxidant, and neuroprotective properties for the treating multiple...
Main Authors: | Baoxia Zhao, Jie Fu, Huadong Ni, Longsheng Xu, Chengfei Xu, Qiuli He, Chaobo Ni, Yahui Wang, Jiao Kuang, Mengjie Tang, Qiyang Shou, Ming Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1010483/full |
Similar Items
-
Beneficial Effects of Catalpol Supplementation during In Vitro Maturation of Porcine Cumulus-Oocyte Complexes
by: Yanxin Wang, et al.
Published: (2023-06-01) -
Protection of catalpol against triptolide-induced hepatotoxicity by inhibiting excessive autophagy via the PERK-ATF4-CHOP pathway
by: Linluo Zhang, et al.
Published: (2022-01-01) -
Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation
by: Si Li, et al.
Published: (2023-09-01) -
Catalpol protects hepatopulmonary syndrome rats against liver and lung injury
by: ZENG Ziyang, et al.
Published: (2024-03-01) -
A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1
by: Dengqiu Xu, et al.
Published: (2020-10-01)